Skip to main content
Brenda Sandmaier, MD, Oncology, Seattle, WA, UW Medicine/University of Washington Medical Center

BrendaMarieSandmaierMD

Oncology Seattle, WA

Hematologic Oncology

Professor, Fred Hutchinson Cancer Center and Professor of Medicine, University of Washington

Dr. Sandmaier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sandmaier's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1986 - 1988
  • Kaiser Permanente Northern California (Santa Clara)
    Kaiser Permanente Northern California (Santa Clara)Residency, Internal Medicine, 1983 - 1986
  • University of Alberta
    University of AlbertaClass of 1983, MD
  • University of Alberta
    University of AlbertaBSc, Genetics, Honors, 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - Present
  • WA State Medical License
    WA State Medical License 1985 - 2025
  • HI State Medical License
    HI State Medical License 2018 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell Transplantation  
    Mary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica
  • Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma  
    Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica

Abstracts/Posters

  • Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Brenda M Sandmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...
    Brenda M Sandmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell ...
    Brenda M Sandmaier, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Other

Press Mentions

  • Dr. Brenda Sandmaier Named President of American Society for Transplantation and Cellular Therapy
    Dr. Brenda Sandmaier Named President of American Society for Transplantation and Cellular TherapyApril 26th, 2022
  • Shop Talk
    Shop TalkSeptember 5th, 2020
  • New Leaders at ASTCT and CIBMTR Provide Guidelines and Measures for Combating COVID-19 and Protecting Transplant Patients
    New Leaders at ASTCT and CIBMTR Provide Guidelines and Measures for Combating COVID-19 and Protecting Transplant PatientsJune 1st, 2020
  • Join now to see all

Grant Support

  • Allogeneic HCT For Hematologic Malignancies: Immune ManipulationsNational Cancer Institute2009–2012
  • Nonmyeloablative Allografts In Dla-Haploidentical Dogs: Engraftment And GVHDNational Heart, Lung, And Blood Institute2007–2010
  • Core--Protocol Management And Coordination Of Multi-Center TrialsNational Heart, Lung, And Blood Institute2006–2010
  • Astatine-211 Conditioning For Nonmyeloablative Hematopoietic Stem Cell AllograftsNational Cancer Institute2006–2010
  • Mixed Chimerism In The Treatment Of LeukemiasNational Cancer Institute2004–2008
  • Nonmyeloablative Allografts In Dla-Haploidentical Dogs:National Heart, Lung, And Blood Institute2006
  • Nonmyeloablative Grafts In Littermate DogsNational Heart, Lung, And Blood Institute2004–2005
  • Nonmyeloablative Grafts In LittermatesNational Heart, Lung, And Blood Institute2001–2003
  • Nomyeloablative Conditioning Regimens--Mixed ChimerismNational Heart, Lung, And Blood Institute1996–2000
  • Role Of Adhesion Molecules In Graft ResistanceNational Cancer Institute1992–1996
  • Immunotherapy Following Transplant For Breast CancerNational Cancer Institute1995
  • Mechanism Of Antibody Facilitated Marrow EngraftmentNational Cancer Institute1990–1994

Professional Memberships

Hospital Affiliations